Simultaneous Blocking of Human Toll-Like Receptors 2 and 4 Suppresses Myeloid Dendritic Cell Activation Induced byMycobacterium bovisBacillus Calmette-Guérin Peptidoglycan
Open Access
- 1 August 2003
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 71 (8) , 4238-4249
- https://doi.org/10.1128/iai.71.8.4238-4249.2003
Abstract
The Mycobacterium bovis bacillus Calmette-Guérin (BCG) cell wall skeleton (CWS) consists of mycolic acids, arabinogalactan, and peptidoglycan (PGN) and activates Toll-like receptor 2 (TLR2) and TLR4. Here we investigated the ability of the essential portion of highly purified BCG CWS to support the TLR agonist function by using the following criteria: myeloid dendritic cell (DC) maturation, i.e., tumor necrosis factor alpha (TNF-α) production and CD83/CD86 up-regulation. The purified PGN region was sufficient to activate TLR2 and TLR4 in mouse DCs and macrophages; in TLR2 and TLR4 double-knockout cells the BCG PGN-mediated TNF-α production ability was completely impaired. Likewise, stimulation with BCG CWS of HEK293 cells expressing either human TLR2 or TLR4, MD-2, and CD14 resulted in NF-κB activation as determined by a reporter assay. Notably, specific blockers of extracellular human TLR2 (an original cocktail of monoclonal antibodies TLR2.45 and TH2.1) and TLR4 (E5531) inhibited BCG CWS-mediated NF-κB activation by 80%. Using this human TLR blocking system, we tested whether human myeloid DC maturation was TLR2 and TLR4 dependent. BCG PGN-mediated DC maturation was blocked by 70% by suppression of both TLR2 and TLR4 and by 30 to 40% by suppression of either of these TLRs. Similar but less profound suppression of BCG CWS-mediated DC maturation was observed. Hence, the presence of BCG PGN is a minimal requirement for activation of both TLR2 and TLR4 in human DCs, unlike the presence of PGNs of gram-positive bacteria, which activate only TLR2. Unexpectedly, however, BCG PGN, unlike BCG CWS, barely activated NF-κB in HEK293 cells coexpressing TLR2 plus TLR1, TLR2 plus TLR4, TLR2 plus TLR6, or TLR2 plus TLR10, suggesting that PGN receptors other than TLR2 and TLR4 present on human DCs but not on HEK293 cells are involved in TLR signaling for DC activation.Keywords
This publication has 52 references indexed in Scilit:
- NALPs: a novel protein family involved in inflammationNature Reviews Molecular Cell Biology, 2003
- TICAM-1, an adaptor molecule that participates in Toll-like receptor 3–mediated interferon-β inductionNature Immunology, 2003
- Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4Nature, 2002
- The adaptor molecule TIRAP provides signalling specificity for Toll-like receptorsNature, 2002
- The Origin of the Synergistic Effect of Muramyl Dipeptide with Endotoxin and PeptidoglycanPublished by Elsevier ,2002
- Essential role of MD-2 in LPS responsiveness and TLR4 distributionNature Immunology, 2002
- Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signalingBiochemical and Biophysical Research Communications, 2002
- Toll-like receptors and innate immunityNature Reviews Immunology, 2001
- Toll-like Receptor 2 (TLR2) and TLR4 Differentially Activate Human Dendritic CellsJournal of Biological Chemistry, 2001
- Maturation of Human Dendritic Cells by Cell Wall Skeleton ofMycobacterium bovisBacillus Calmette-Guérin: Involvement of Toll-Like ReceptorsInfection and Immunity, 2000